Proteomic study backs up link between plaque and heart disease
14 May, 2003 by Jeremy TorrMelbourne University proteomic research has indicated a possible link between oral hygiene and heart disease.
Gene patents: pathologists call on govts to challenge GTG
12 May, 2003 by Melissa TrudingerA row is brewing between the Royal College of Pathologists Australasia and Genetic Technologies, the Melbourne-based biotechnology company that last year obtained an exclusive license to offer Myriad Genetics' BRCA1 and BRCA2 breast cancer susceptibility tests in Australia and New Zealand.
Its genome sequenced, SARS patents proliferate
12 May, 2003 by Jeremy TorrFollowing intense activity around the globe, researchers have identified critical aspects of the SARS genome -- and now the race is on to file patents.
Queensland bio braces for the future
12 May, 2003 by Pete YoungThanks to a massive infrastructure funding boost from a government led by bio-enthusiast Premier Peter Beattie, Queensland got off to a fast start in biotechnology. But, asks Pete Young, is the venture capital bottleneck pushing its plans off track?
Flying the flag for bioinformatics
29 April, 2003 by David BraueDavid Braue discovers why the upcoming ISMB conference in Brisbane is likely to boost the profile of bioinformatics in Australia.
Winds of change
29 April, 2003 by Pete YoungAs the winds of change whistle through the life sciences industry in Australia and overseas, some bio-IT trends are also changing, a poll of the major vendors reveals.
Happy together
24 April, 2003 by David BinningWhen it comes to clustering, Australian biotech could take a few lessons from the nation's wine industry -- and not just the grapes, David Binning finds.
Nobel laureate Sulston critical of 'greedy' IP
24 April, 2003 by Graeme O'NeillHistory students and trivia buffs in the distant future time will be grateful for one of history's little coincidences -- the Human Genome Project will be completed this year, 2003, a neat half-century after the elucidation of the structure of DNA.
Vindication for proteomics in research on ageing
23 April, 2003 by Graeme O'NeillGeneticists at the National Human Genome Research Institute in Washington last week celebrated the publication of the identity of the faulty gene involved in a devastating premature-ageing disorder. But it was only half the story -- an Australian collaboration has provided a bigger picture, reports Graeme O'Neill.
Proteome Systems moves to contract work
17 April, 2003 by Jeremy TorrPlatform technology company Proteome Systems is to offer its first contract-fee based operation in a joint initiative with Massachusetts-based Charles River Laboratories (CRL).
Discovery unlocks sectrets of Down syndrome immune defects
17 April, 2003 by Melissa TrudingerScientists at the Monash Institute of Reproduction and Development's Centre for Functional Genomics and Human Disease have identified a transcription factor gene on chromosome 21 that may help to explain the immune system defects common to Down syndrome patients.
Researchers discover SARS' genetic blueprint
14 April, 2003 by Jeremy TorrResearchers in Canada and the US have reported success in isolating and mapping a likely culprit for the recent outbreak of SARS.
ASX to teach investors how to approach biotech
11 April, 2003 by Melissa TrudingerAustralian investors tend to adopt a herd mentality and this is making it difficult for listed Australian biotechnology companies to retain their liquidity and make inroads into the investment community, the Australian Stock Exchange's James Gerraty told attendees at an AusBiotech roadshow in Melbourne this week.
New find exposes apoptosis drug challenge
03 April, 2003 by Melissa TrudingerThe three-dimensional structure of the anti-apoptosis protein Bcl-w has unexpectedly revealed a protective 'tail' which sits in a groove preventing cell death from being triggered accidentally, explaining why attempts at designing drugs capable of specifically triggering cell death may be more challenging than first appreciated.
GTG sues 'major US companies' for patent infringements
02 April, 2003 by Melissa TrudingerMelbourne company Genetic Technologies has filed lawsuits against three major US companies for infringement of the company's non-coding DNA patents.
